Gyula Acsádi

10.7k citations

70 papers · 7.5k indexed · 2 hit papers · h-index 32

Molecular Biology top 1%
Genetics top 0.5%
Immunology top 2%
Genetics top 0.5%
Infectious Diseases top 2%

Co-authors: Ágnes Jáni Jon A. Wolff Chong Wang Philip L. Felgner Phillip Williams Robert W. Malone George Karpati A Jani
Topics: Virus-based gene therapy research (19 papers)Neurogenetic and Muscular Disorders Research (17 papers)Muscle Physiology and Disorders (15 papers)
Cited by: Genetics Molecular Biology
Journals: Nature Science Journal of Biological Chemistry
Partner nations: United States Canada Italy

In The Last Decade

Gyula Acsádi

66 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct Gene Transfer into Mouse Muscle in Vivo

1990 3.2k citations Jon A. Wolff, Gyula Acsádi et al. profile →
Long-term persistence of plasmid DNA and foreign gone expression in mouse muscle

1992 619 citations Jon A. Wolff, Gyula Acsádi et al. profile →

Peers

Countries citing papers authored by Gyula Acsádi

Since Specialization

Citations

This map shows the geographic impact of Gyula Acsádi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gyula Acsádi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gyula Acsádi more than expected).

Fields of papers citing papers by Gyula Acsádi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gyula Acsádi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gyula Acsádi. The network helps show where Gyula Acsádi may publish in the future.

Co-authorship network of co-authors of Gyula Acsádi

This figure shows the co-authorship network connecting the top 25 collaborators of Gyula Acsádi. A scholar is included among the top collaborators of Gyula Acsádi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gyula Acsádi. Gyula Acsádi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stance and swing phase ankle phenotypes in youth with Charcot-Marie-Tooth type 1: An evaluation using comprehensive gait analysis techniques 2022 ·Gait & Posture ·Sylvia Õunpuu,Kristan Pierz,Erin J. Garibay,Gyula Acsádi,Tishya A. L. Wren	3
2	Comparison of gait patterns and functional measures between Charcot-Marie-Tooth disease type I and II in children to young adults 2020 ·Gait & Posture ·(unknown),Erin J. Garibay,Kristan Pierz,Gyula Acsádi,Sylvia Õunpuu	10
3	Safety and Efficacy of Nusinersen in Infants/Children with Spinal Muscular Atrophy (SMA): Part 1 of the Phase 2 EMBRACE Study (P2.324) 2018 ·Neurology ·Perry B. Shieh,Gyula Acsádi,Wolfgang Mueller‐Felber,Thomas O. Crawford,Randal Richardson,(unknown),Diana Castro,Sarah Gheuens,Ishir Bhan,Giulia Gambino,Peng Sun,Wildon Farwell,Sandra P. Reyna	2
4	Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation 2017 ·Pediatric Neurology ·(unknown),Kenneth Silver,(unknown),Suzanne D. DeBrosse,(unknown),Kathryn J. Swoboda,Gyula Acsádi	47
5	Pediatric Charcot-Marie-Tooth Disease 2015 ·Pediatric Clinics of North America ·Agnes Jani‐Acsadi,Sylvia Õunpuu,Kristan Pierz,Gyula Acsádi	35
6	Validation of the Charcot–Marie–Tooth disease pediatric scale as an outcome measure of disability 2012 ·Annals of Neurology ·Joshua Burns,Robert Ouvrier,Tim Estilow,Rosemary Shy,Matilde Laurá,Julie Pallant,Monkol Lek,Francesco Muntoni,Mary M. Reilly,Davide Pareyson,Gyula Acsádi,Michael E. Shy,Richard S. Finkel	124
7	Functional consequences and structural interpretation of mutations of human choline acetyltransferase 2011 ·Human Mutation ·Xin‐Ming Shen,Thomas O. Crawford,Joan M. Brengman,Gyula Acsádi,(unknown),Emin Karaca,(unknown),Jean K. Mah,Simon Edvardson,Željko Bajzer,David W. Rodgers,Andrew G. Engel	30
8	Alpha-Synuclein Loss in Spinal Muscular Atrophy 2010 ·Journal of Molecular Neuroscience ·Gyula Acsádi,Xingli Li,Kelley J. Murphy,Kathryn J. Swoboda,Graham C. Parker	12
9	SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy 2010 ·PLoS ONE ·Kathryn J. Swoboda,Charles Scott,Thomas O. Crawford,Louise R. Simard,Sandra P. Reyna,Kristin J. Krosschell,Gyula Acsádi,(unknown),Mary Schroth,Guy D’Anjou,Bernard LaSalle,Thomas W. Prior,(unknown),Jo Anne Maczulski,Mark B. Bromberg,Gary M. Chan,John T. Kissel,(unknown)	124
10	Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy 2009 ·PLoS ONE ·Kathryn J. Swoboda,Charles Scott,Sandra P. Reyna,Thomas W. Prior,Bernard LaSalle,(unknown),Janine Wood,Gyula Acsádi,Thomas O. Crawford,John T. Kissel,Kristin J. Krosschell,Guy D’Anjou,Mark B. Bromberg,Mary Schroth,Gary M. Chan,Bakri Elsheikh,Louise R. Simard	132
11	Survival motor Neuron protein regulates apoptosis in anin vitro model of Spinal muscular atrophy 2008 ·Neurotoxicity Research ·Graham C. Parker,Xingli Li,(unknown),(unknown),(unknown),Gyula Acsádi	41
12	Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells 1998 ·Journal of Molecular Medicine ·Gyula Acsádi,David O’Hagan,Hanns Lochmüller,Stephen M. Prescott,Nancy Larochelle,Joséphine Nalbantoglu,Ágnes Jáni,George Karpati	21
13	Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA 1997 ·Journal of Virological Methods ·Ágnes Jáni,(unknown),Gyula Acsádi,(unknown),Johnny Huard,Alain Garnier,George Karpati,Bernard Massie	26
14	Toxicity of Replication-Defective Adenoviral Recombinants in Dissociated Cultures of Nervous Tissue 1996 ·Experimental Neurology ·Heather D. Durham,Hanns Lochmüller,Ágnes Jáni,Gyula Acsádi,Bernard Massie,George Karpati	30
15	Efficiency and Functional Consequences of Adenovirus-Mediated In Vivo Gene Transfer to Normal and Dystrophic (Mdx) Mouse Diaphragm 1995 ·American Journal of Respiratory Cell and Molecular Biology ·Basil J. Petrof,Gyula Acsádi,A Jani,B. Massie,Johanne Bourdon,(unknown),Liying Yang,Hanns Lochmüller,George Karpati	31
16	Adenovirus-mediated gene transfer into striated muscles 1995 ·Journal of Molecular Medicine ·Gyula Acsádi,A Jani,B. Massie	32
17	Gene Transfer into Skeletal Muscles by Isogenic Myoblasts 1994 ·Human Gene Therapy ·Johnny Huard,Gyula Acsádi,Ágnes Jáni,Bernard Massie,George Karpati	154
18	Persistence of plasmid DNA and expression in rat brain cells in vivo 1992 ·Experimental Neurology ·Shoushu Jiao,Gyula Acsádi,Ágnes Jáni,Philip L. Felgner,Jon A. Wolff	79
19	Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs 1991 ·Nature ·Gyula Acsádi,George Dickson,Donald R. Love,Ágnes Jáni,Frank S. Walsh,Asitha Gurusinghe,Jon A. Wolff,Kay E. Davies	382
20	L-Carnitine Replacement Therapy in Chronic Valproate Treatment 1990 ·Neuropediatrics ·Béla Melegh,János Kerner,Gyula Acsádi,(unknown),Attila Sándor	26

About Gyula Acsádi

Gyula Acsádi is a scholar working on Genetics, Cellular and Molecular Neuroscience and Neurology, having authored 70 papers that have together received 7.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (19 papers), Neurogenetic and Muscular Disorders Research (17 papers) and Muscle Physiology and Disorders (15 papers). The work is most often cited by research in Genetics (2.9k citations), Genetics (1.1k citations) and Molecular Biology (5.0k citations). Gyula Acsádi has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Ágnes Jáni, Jon A. Wolff, Chong Wang, Philip L. Felgner, Phillip Williams, Robert W. Malone, George Karpati, A Jani, James J. Ludtke and Philip M. Williams. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact